Trial intelligence / Profile preview

RESTORE: Tacrolimus + Sirolimus vs Tacrolimus + MMF in Kidney Transplantation

NCT00296361Phase 3Completed

Sponsor
Astellas Pharma
Start
Oct 2004
Primary completion
Jul 2006
Modality
RNA-Targeting Small Molecules
Countries
14
01

Overview

A Phase 3 trial of tacrolimus in kidney transplant rejection, sponsored by Astellas Pharma. Started Oct 2004; status: completed.

02

Drugs

tacrolimus
03

Conditions

kidney transplant rejection

Beyond the preview

Go deeper on NCT00296361.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00296361.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call